The Cell and Molecular Biology Core provides essential services for the proposed Program Project. The capabilities of cellular and molecular biology have only recently been harnessed in our studies which focus on pathophysiological characteristics of solid tumors. We have thus assembled as part of our program, a team of cellular and molecular biologists to assist in the investigation of the relationships between tumor physiology and the expression of molecular determinants to assist in the investigation of the relationships between tumor physiology and the expression of molecular determinants. The facilities and services of this important Core will provide on-site expertise, equipment, and assay protocols to our Project Leaders who are primarily biomedical engineers with relatively limited experience in molecular, cellular and morphological techniques. The molecular biology component of the Core will provide the expertise, equipment, assay protocols, and essential reagents for the characterization of gene expression and protein distribution. These routine services will include the isolation and purification of DNA, RNA and proteins, in situ hybridization, Southern, Northern and Western assays, generation of DNA constructs, and modification of tumor cell lines by transfection and genotyping characterization. The cellular biology component will provide the expertise and services for cell culture (maintenance of tumor cell lines and genetically transfected cell lines, quality control, and maintenance of supplies). The morphology component will provide the expertise and routine services for histology and immunolabeling (providing equipment, supplies and protocols, fixation, embedding and sectioning of tissues, and staining using established immunohistochemical and immunocytochemical procedures). In addition to provide strategic consultation in the design of experimental procedures, to introduce state- of-the-art techniques, and assist in the completion of experiments and interpretation of data for molecular, cellular and morphology studies. Finally, the Core personnel will assure reagent and antibody quality, manage biological information (e.g DNA, protein sequences from Genbank), acquire and store research materials, and maintain essential logs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA080124-01A1
Application #
6402415
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2000-08-11
Project End
2005-07-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Khandekar, Melin J; Jain, Rakesh (2018) Smooth sailing for immunotherapy for unresectable stage III non-small cell lung cancer: the PACIFIC study. Transl Cancer Res 7:S16-S20
Stylianopoulos, Triantafyllos; Munn, Lance L; Jain, Rakesh K (2018) Reengineering the Tumor Vasculature: Improving Drug Delivery and Efficacy. Trends Cancer 4:258-259
Grassberger, Clemens; Hong, Theodore S; Hato, Tai et al. (2018) Differential Association Between Circulating Lymphocyte Populations With Outcome After Radiation Therapy in Subtypes of Liver Cancer. Int J Radiat Oncol Biol Phys 101:1222-1225
Zhang, Na; Chen, Jie; Ferraro, Gino B et al. (2018) Anti-VEGF treatment improves neurological function in tumors of the nervous system. Exp Neurol 299:326-333
Aoki, Shuichi; Cobbold, Mark; Zhu, Andrew X et al. (2018) Can smart nanomedicine deliver effective targeted cytotoxic treatments to hepatocellular carcinomas while reducing the liver damage? Hepatology 67:826-828
Li, Wende; Liu, Yujiao; Yang, Weining et al. (2018) MicroRNA-378 enhances radiation response in ectopic and orthotopic implantation models of glioblastoma. J Neurooncol 136:63-71
Griveau, Amelie; Seano, Giorgio; Shelton, Samuel J et al. (2018) A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment. Cancer Cell 33:874-889.e7
Stylianopoulos, Triantafyllos; Munn, Lance L; Jain, Rakesh K (2018) Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside. Trends Cancer 4:292-319
Incio, Joao; Ligibel, Jennifer A; McManus, Daniel T et al. (2018) Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2. Sci Transl Med 10:
Sung, Yun-Chieh; Liu, Ya-Chi; Chao, Po-Han et al. (2018) Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development. Theranostics 8:894-905

Showing the most recent 10 out of 320 publications